02/13
Headlines

NYSE:JNJ

Healthcare active runners: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD)

Jason Knox02 mins

On Monday, Johnson & Johnson (NYSE:JNJ) announced that it accepted the binding offer from The Carlyle Group (NASDAQ:CG), which was received and announced on January 16, 2014, to acquire its Ortho-Clinical Diagnostics business for approximately $4 Billion, subject to customary adjustments. Johnson & Johnson (NYSE:JNJ) stock performance was 0.16% in last session and finished the…

Read More

DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY), AbbVie Inc (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ)

Chris Lewis03 mins

Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site. In a joint announcement, Gov. Dannel P. Malloy and Pfizer confirmed that two buildings…

Read More

Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Bristol-Myers Squibb (NYSE:BMY)

Jayne Crisman03 mins

Three years after Pfizer Inc. (NYSE:PFE) announced more than 1,000 layoffs that Gov. Dannel P. Malloy at the time called “terrible news,” the pharmaceutical company and the state said Wednesday they’ve come up with new uses for the Groton site. Malloy and top officials of his administration and Pfizer Inc (NYSE:PFE) said two vacant buildings…

Read More

Trending Stocks: Biogen Idec (NASDAQ:BIIB), The Procter & Gamble (NYSE:PG), Epizyme Inc (NASDAQ:EPZM), Johnson & Johnson (NYSE:JNJ)

Jason Knox02 mins

Biogen Idec Inc. (NASDAQ:BIIB) announced it will report first quarter 2014 financial results on Wednesday, April 23, 2014, before the financial markets open. Biogen Idec Inc (NASDAQ:BIIB) stock performance was 1.28% in last session and finished the day at $309.79. Traded volume was 1.71million shares in the last session and the average volume of the…

Read More

Healthcare Active Runners: Merck & Co. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Ariad Pharmaceuticals (NASDAQ:ARIA)

Kevin Long02 mins

Merck & Co., Inc. (NYSE:MRK) is getting close to conducting phase 3 trials for a combination treatment for Hepatitis C, which could potentially rejuvenate the pharmaceutical giant’s revenue growth. The clinical data for a combination of drugs MK-5172 and MK-8742 has showed high cure rates among patients with genotype 1 of the disease, and this…

Read More

Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Inovio Pharmaceuticals (NYSEMKT:INO), Johnson & Johnson (NYSE:JNJ)

Jayne Crisman02 mins

Pfizer Inc. (NYSE:PFE) announced encouraging top-line data from a phase IIIb study evaluating Genotropin for increasing height in small-for-gestational-age (SGA) children aged between 24 and 30 months. Pfizer Inc. (NYSE:PFE) stock performance was -0.25% in last session and finished the day at $32.10. Traded volume was 27.74million shares in the last session and the average…

Read More